© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
October 05, 2021
People who inject drugs are at high-risk for HIV infection, but very few are interested in PrEP prescriptions.
September 29, 2021
Mortality rates of children with HIV may be underreported due to lack of patient follow-up and the usage of routine program data.
September 28, 2021
Cabotegravir has a target date of January 24, 2022 and would become the first long-acting HIV PrEP therapy approved.
September 27, 2021
England has been meeting and exceeding its HIV diagnosis and treatment goals set by UNAIDS.
September 26, 2021
Parentless youth living on the streets had the highest rates of HIV and death, but extended-family living situations were not necessarily better than institutional care.
September 24, 2021
The therapy, known as EBT-101, works by eliminating HIV-infected DNA from the genome.
September 22, 2021
To address PrEP implementation in Kenya, a team of researchers evaluated practices and contextual modifications across public HIV clinics.
September 20, 2021
Antiretroviral therapy for HIV offers a protective outcome against preterm birth for pregnant women with HIV.
September 19, 2021
The University of Miami (UM) has a community-based mobile clinic that offers PrEP counseling along with other medical services to those who might not otherwise have access to or seek clinical care.
September 15, 2021
Higher HIV viral loads and additional heart disease factors increase the risk as well.